Prevalence, drug resistance, and genotypic diversity of the RDRio subfamily of Mycobacterium tuberculosis in Ecuador: a retrospective analysis for years 2012–2016

Bernardo Castro-RodrÃŁguez,Greta Franco-Sotomayor,Jose Manuel Benitez-Medina,Greta Cardenas-Franco,Natalia Jiménez-Pizarro,Camilo Cardenas-Franco,Juan Luis Aguirre-Martinez,Solon Alberto Orlando,Javier Hermoso de Mendoza,Miguel Angel Garcia-Bereguiain
DOI: https://doi.org/10.3389/fpubh.2024.1337357
IF: 5.2
2024-04-05
Frontiers in Public Health
Abstract:Introduction: A major sublineage within the Mycobacterium tuberculosis (MTB) LAM family characterized by a new in-frame fusion gene Rv3346c/55c was discovered in Rio de Janeiro (Brazil) in 2007, called RD Rio , associated to drug resistance. The few studies about prevalence of MTB RD Rio strains in Latin America reported values ranging from 3% in Chile to 69.8% in Venezuela, although no information is available for countries like Ecuador. Methods: A total of 814 MTB isolates from years 2012 to 2016 were screened by multiplex PCR for RD Rio identification, followed by 24-loci MIRU-VNTR and spoligotyping. Results: A total number of 17 MTB RD Rio strains were identified, representing an overall prevalence of 2.09% among MTB strains in Ecuador. While 10.9% of the MTB isolates included in the study were multidrug resistance (MDR), 29.4% (5/17) of the RD Rio strains were MDR. Discussion: This is the first report of the prevalence of MTB RD Rio in Ecuador, where a strong association with MDR was found, but also a very low prevalence compared to other countries in Latin America. It is important to improve molecular epidemiology tools as a part of MTB surveillance programs in Latin America to track the transmission of potentially dangerous MTB stains associated to MDR TB like MTB RD Rio .
public, environmental & occupational health
What problem does this paper attempt to address?